Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiano Filetti

Showing results (21-30 of 154) with videos related to

Pageof 16
Sort By:
Nature Clinical Practice. Endocrinology & Metabolism|February 23, 2007
Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patientsMartin Schlumberger, Ludovic Lacroix, Diego Russo, et al.
The Lancet. Diabetes & Endocrinology|October 9, 2019
Screening for differentiated thyroid cancer in selected populationsLivia Lamartina, Giorgio Grani, Cosimo Durante, et al.
The Lancet. Diabetes & Endocrinology|November 6, 2017
Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical managementGiorgio Grani, Livia Lamartina, Cosimo Durante, et al.
Nature Reviews. Endocrinology|August 3, 2018
Follow-up of differentiated thyroid cancer - what should (and what should not) be doneLivia Lamartina, Giorgio Grani, Cosimo Durante, et al.
Molecular and Cellular Endocrinology|September 18, 2012
The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell linesElisa Lavarone, Cinzia Puppin, Nadia Passon, et al.
Annals of Clinical Biochemistry|March 8, 2008
Thyrotoxic periodic paralysis in an Italian man: clinical manifestation and genetic analysisFrancesco Vendrame, Antonella Verrienti, Claudio Parlapiano, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 25, 2014
Pharmacokinetics, pharmacodynamics and clinical efficacy of dapagliflozin for the treatment of type 2 diabetesMarianna Maranghi, Anna Carnovale, Cosimo Durante, et al.
Journal of Cancer Research and Clinical Oncology|December 4, 2017
Effects of nutraceuticals on anaplastic thyroid cancer cellsLorenzo Allegri, Francesca Rosignolo, Catia Mio, et al.
European Journal of Endocrinology|March 15, 2005
Subclinical hyperthyroidism: clinical features and treatment optionsBernadette Biondi, Emiliano Antonio Palmieri, Michele Klain, et al.
Endocrine|May 14, 2016
The true cost of thyroid surgery determined by a micro-costing approachSebastiano Filetti, Paul W Ladenson, Marco Biffoni, et al.
Pageof 16

Showing results (21-30 of 154) with videos related to

Sort By:
Pageof 16
Nature Clinical Practice. Endocrinology & Metabolism|February 23, 2007
Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patientsMartin Schlumberger, Ludovic Lacroix, Diego Russo, et al.
The Lancet. Diabetes & Endocrinology|October 9, 2019
Screening for differentiated thyroid cancer in selected populationsLivia Lamartina, Giorgio Grani, Cosimo Durante, et al.
The Lancet. Diabetes & Endocrinology|November 6, 2017
Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical managementGiorgio Grani, Livia Lamartina, Cosimo Durante, et al.
Nature Reviews. Endocrinology|August 3, 2018
Follow-up of differentiated thyroid cancer - what should (and what should not) be doneLivia Lamartina, Giorgio Grani, Cosimo Durante, et al.
Molecular and Cellular Endocrinology|September 18, 2012
The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell linesElisa Lavarone, Cinzia Puppin, Nadia Passon, et al.
Annals of Clinical Biochemistry|March 8, 2008
Thyrotoxic periodic paralysis in an Italian man: clinical manifestation and genetic analysisFrancesco Vendrame, Antonella Verrienti, Claudio Parlapiano, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 25, 2014
Pharmacokinetics, pharmacodynamics and clinical efficacy of dapagliflozin for the treatment of type 2 diabetesMarianna Maranghi, Anna Carnovale, Cosimo Durante, et al.
Journal of Cancer Research and Clinical Oncology|December 4, 2017
Effects of nutraceuticals on anaplastic thyroid cancer cellsLorenzo Allegri, Francesca Rosignolo, Catia Mio, et al.
European Journal of Endocrinology|March 15, 2005
Subclinical hyperthyroidism: clinical features and treatment optionsBernadette Biondi, Emiliano Antonio Palmieri, Michele Klain, et al.
Endocrine|May 14, 2016
The true cost of thyroid surgery determined by a micro-costing approachSebastiano Filetti, Paul W Ladenson, Marco Biffoni, et al.
Pageof 16